-
COX-2 Timing in Venom-Induced Muscle Revascularization
2026-09-24
A mouse model of Bothrops asper venom injury reveals that COX-2 has a time-dependent role: its activity helps limit early muscle ischemia, while early inhibition is associated with stronger later angiogenic and matrix-remodeling signals. The findings distinguish immediate vascular protection from subsequent revascularization and caution against interpreting angiogenic markers alone as evidence of restored blood flow.
-
Gastrin I (human): Reliable Assay Design
2026-09-24
Practical guidance for selecting, preparing, and interpreting Gastrin I (human) in gastric acid secretion and cell-based studies. This scenario-driven guide explains what SKU B5358 supports, how to handle its formulation, and where intestinal organoid evidence should—and should not—be applied.
-
CAF–ANGPTL4–IQGAP1 Axis in Prostate Cancer
2026-09-23
The reference study identifies a paracrine mechanism by which cancer-associated fibroblasts promote mitochondrial biogenesis, oxidative phosphorylation, and chemotherapy resistance in prostate cancer. Its findings connect CAF-derived ANGPTL4 to membrane-associated IQGAP1 and downstream Raf–MEK–ERK–PGC1α signaling, while also supporting IQGAP1-directed intervention as a potential strategy for improving docetaxel responsiveness.
-
Phosphorylation as a Translational Control Point
2026-09-23
Phosphorylation-dependent mobility shifts can connect mechanistic biology with practical assay development. Using the CaMKIIδ–BMAL1 findings from an ISX-9 circadian study as a case study, this article explains how Phosbind Acrylamide can support antibody-free protein phosphorylation analysis, where it complements immunoblotting and mass spectrometry, and how translational teams can interpret the resulting evidence without overstating what a gel shift proves.
-
Ginsenoside Rg1: Reliable Assay Workflows
2026-09-22
This scenario-based guide explains how Ginsenoside Rg1 (SKU N1613) can support reproducible cell viability, apoptosis, inflammation, and neuroprotection research. It links formulation, handling, controls, and recent neuroimmune evidence to practical laboratory decisions.
-
CIP2A, PKM2, and OXPHOS in NSCLC
2026-09-21
The reference study identifies CIP2A as a regulator that shifts PKM2 toward tetramer formation, mitochondrial localization, and oxidative phosphorylation in non-small cell lung cancer. Its mechanistic and intervention data suggest that combined targeting of CIP2A and glycolysis may expose a metabolic vulnerability in NSCLC, while also highlighting the need to measure both glycolytic and respiratory phenotypes.
-
Alfuzosin HCl: Applied Research Workflows
2026-09-21
Build reproducible Alfuzosin HCl assays for fluorescence quantitation, formulation release, and functional urology research. This guide translates a micellar spectrofluorimetric method into practical workflows while separating analytical detection from α1-receptor pharmacology.
-
ML216: BLM Helicase Inhibition with Assay Insight
2026-09-20
ML216 is a selective BLM helicase inhibitor for dissecting DNA repair, homologous recombination, and tumor cell responses to genotoxic stress. This article explains how to use ML216 mechanistically while distinguishing BLM-focused experiments from WRN and mismatch-repair research.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-19
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for investigating autophagy pathway modulation and TLR7/9-associated immune signaling in autoimmune disease research. It is best suited to freshly prepared, water-based workflows and should be avoided when a protocol requires DMSO or ethanol solubility or prolonged storage of prepared solutions.
-
Spatial Lipid Changes in Postoperative Cognitive Dysfunction
2026-09-19
This rat cardiopulmonary bypass study combines spatial metabolomics, enzyme imaging, ultrastructural analysis, and metabolic rescue experiments to connect hippocampal CA1 lipid remodeling with postoperative cognitive dysfunction. Its findings implicate reduced iPLA2 activity, increased SPT expression, and synaptic damage as potentially linked features that can be partially normalized by DHA and myriocin.
-
Triiodothyronine (T3) in Thermogenesis Assays
2026-09-18
Use Triiodothyronine (T3) to add a controlled thyroid hormone receptor perturbation to beige adipocyte, mitochondrial respiration, and gene-expression workflows. This guide translates SEMA3E–β-catenin findings into practical assay designs, dose screens, controls, and troubleshooting decisions for metabolic disorder research.
-
LL-37 Against MDR Acinetobacter Biofilms
2026-09-18
The reference study shows that human cathelicidin LL-37 and selected fragments can rapidly kill multidrug-resistant Acinetobacter baumannii while also preventing and disrupting biofilms. Its comparative design links planktonic susceptibility, rapid bactericidal activity, adherence, biofilm eradication, and cytotoxicity, offering a useful framework for evaluating anti-infective peptide candidates.
-
BIIE 0246: Y2R Workflows for Neural Research
2026-09-17
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating Y2R signaling from Y1R-driven effects in synaptic, feeding, anxiety, gut, and neurocardiac assays. This practical guide translates its nanomolar pharmacology into reproducible workflows, controls, and troubleshooting strategies for NPY pathway research.
-
Dantrolene sodium salt in calcium-aware CRISPR
2026-09-17
Dantrolene sodium salt provides a practical way to perturb ryanodine receptor–mediated calcium release while preserving a clear distinction between calcium biology and direct DNA-repair pharmacology. This guide translates its mechanism into calcium imaging, pancreatitis, disease-modeling, and exploratory CRISPR workflows with dose, control, and troubleshooting strategies.
-
Nelfinavir Mesylate in HIV and Ferroptosis Assays
2026-09-16
Nelfinavir Mesylate supports both HIV-1 protease inhibition assays and mechanistic studies of DDI2-NFE2L1 control during ferroptosis. This guide translates potency data and the latest proteostasis findings into practical workflows, controls, and troubleshooting decisions.